BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22549011)

  • 1. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
    Shin HC; Cho H; Lai TC; Kozak KR; Kolesar JM; Kwon GS
    J Control Release; 2012 Oct; 163(1):93-9. PubMed ID: 22549011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.
    Cho H; Kwon GS
    J Drug Target; 2014 Aug; 22(7):669-77. PubMed ID: 24964052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.
    Shin HC; Alani AW; Cho H; Bae Y; Kolesar JM; Kwon GS
    Mol Pharm; 2011 Aug; 8(4):1257-65. PubMed ID: 21630670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.
    Shin DH; Kwon GS
    Int J Pharm; 2017 Feb; 518(1-2):307-311. PubMed ID: 28062368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
    Tam YT; Gao J; Kwon GS
    J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-drug delivery to tumor cells via micellar nanocarriers.
    Katragadda U; Teng Q; Rayaprolu BM; Chandran T; Tan C
    Int J Pharm; 2011 Oct; 419(1-2):281-6. PubMed ID: 21820041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade.
    Mishra GP; Nguyen D; Alani AW
    Mol Pharm; 2013 May; 10(5):2071-8. PubMed ID: 23590802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.
    Shin HC; Alani AW; Rao DA; Rockich NC; Kwon GS
    J Control Release; 2009 Dec; 140(3):294-300. PubMed ID: 19409432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug PLA-PEG filomicelles for concurrent delivery of anticancer drugs-The influence of drug-drug and drug-polymer interactions on drug loading and release properties.
    Jelonek K; Li S; Kaczmarczyk B; Marcinkowski A; Orchel A; Musiał-Kulik M; Kasperczyk J
    Int J Pharm; 2016 Aug; 510(1):365-74. PubMed ID: 27346726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triolimus: A Multi-Drug Loaded Polymeric Micelle Containing Paclitaxel, 17-AAG, and Rapamycin as a Novel Radiosensitizer.
    Tomoda K; Tam YT; Cho H; Buehler D; Kozak KR; Kwon GS
    Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27365266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis.
    Katragadda U; Fan W; Wang Y; Teng Q; Tan C
    PLoS One; 2013; 8(3):e58619. PubMed ID: 23505544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.
    Cho H; Gao J; Kwon GS
    J Control Release; 2016 Oct; 240():191-201. PubMed ID: 26699425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.
    Xiong MP; Yáñez JA; Kwon GS; Davies NM; Forrest ML
    J Pharm Sci; 2009 Apr; 98(4):1577-86. PubMed ID: 18752263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Stability and Plasma Metabolite Concentration-Time Profiles of Oligo(Lactic Acid)
    Repp L; Skoczen SL; Rasoulianboroujeni M; Stern ST; Kwon GS
    AAPS J; 2023 Apr; 25(3):39. PubMed ID: 37041376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations.
    Tsallas A; Jackson J; Burt H
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):431-44. PubMed ID: 21069339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.
    Ouahab A; Shao C; Shen Y; Tu J
    Drug Dev Ind Pharm; 2014 Jul; 40(7):860-8. PubMed ID: 23600653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.